The basis of molecular strategies for treating coronary restenosis after angioplasty
- 31 May 1994
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 23 (6) , 1278-1288
- https://doi.org/10.1016/0735-1097(94)90368-9
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factorPublished by Elsevier ,2004
- The rat angiotensin II AT1A receptor couples with three different signal transduction pathwaysBiochemical and Biophysical Research Communications, 1992
- The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclaseBiochemical and Biophysical Research Communications, 1992
- The p53 tumour suppressor geneNature, 1991
- What Controls the Cell CycleScientific American, 1991
- Protein kinases and protooncogenes: biochemical regulators of the eukaryotic cell cycleBiochemistry, 1991
- The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory elementCell, 1989
- Production of Platelet-Derived Growth Factor–like Mitogen by Smooth-Muscle Cells from Human AtheromaNew England Journal of Medicine, 1988
- Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cellsAtherosclerosis, 1987
- Nonoperative Dilatation of Coronary-Artery StenosisNew England Journal of Medicine, 1979